Insmed

Powered by Purpose

Culture
Our Culture

Mission & Vision

Careers

Our Global Company

Find available career opportunities in the U.S., Japan, or Europe.

Find Jobs
Patients
Our Patients

Disease Areas

Resources

Patient Access

Current Clinical Trials

You may be eligible for one of our clinical trials.

See if you may qualify
Science
Our Science

Our Pillars

ARIKAYCE^®

Brensocatib

TPIP

Early-Stage Research

Pipeline

Clinical Trials

Investigator-Initiated Research

Grants & Funding

Discovery Dialogues at Insmed

Sit down with members of Insmed’s global Research team as they discuss our approach to developing life-transforming medicines while tackling some of the most pressing scientific challenges today.

Watch the videos
Responsibility
Our Responsibility

Our Commitments

Inclusion at Insmed

Global Healthcare Compliance

Policies and Disclosures

Responsibility Report

Our Responsibility Report reflects the culture and purpose we live by every day. We are committed to reporting annually on our progress and commitments.

Learn More
About
Investors

News Releases

Month Year

Month Year

Dec 15, 2003

Insmed Receives FDA Orphan Drug Designation For rhIGF-I/rhIGFBP-3, SomatoKine, for Extreme Insulin Resistance
Dec 3, 2003

Insmed Presents Positive Data on Anti-Cancer Drug Candidate to San Antonio Breast Cancer Symposium
Dec 2, 2003

rhIGF-I/rhIGFBP-3, SomatoKine, Found to Delay the Onset of Type I Diabetes

rhIGF-I/rhIGFBP-3, SomatoKine, Found to Delay the Onset of Type I Diabetes
Nov 17, 2003

Insmed Presents Positive Data on Anti-Cancer Drug Candidate to AACR-NCI-EORTC
Nov 5, 2003

Insmed to Present Cancer Data to CaP Cure, the Prostate Cancer Foundation
Nov 5, 2003

Insmed Incorporated Reports Financial Results for Third Quarter 2003 and Nine-Months Ended September 30, 2003
Oct 28, 2003

Insmed Incorporated to Webcast Third Quarter Earnings Conference Call; Wednesday, November 5, at 11:00 a.m. ET - 10:00 a.m. CT
Oct 16, 2003

Insmed to Present to Rodman and Renshaw Healthcare Conference; Presentation to be Webcast Live

Insmed to Present to Rodman and Renshaw Healthcare Conference; Presentation to be Webcast Live
Sep 23, 2003

Insmed to Offer Data Showing Efficacy of Drug Candidate in Breast Cancer

Insmed to Offer Data Showing Efficacy of Drug Candidate in Breast Cancer
Sep 15, 2003

Insmed's Phase III Drug Candidate to Be Featured in Two Podium Presentations at European Society for Paediatric Endocrinology

Insmed's Phase III Drug Candidate to Be Featured in Two Podium Presentations at European Society for Paediatric Endocrinology

Show per page

Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your
email alerts.

View the latest Insmed Investor Presentation